Table 2.
Characteristics of Participants Included in the Study
| Condition | DR Group | HC Group | T/χ2 values | P-value* |
|---|---|---|---|---|
| Gender (male/female) | 18/17 | 18/20 | 0.011 | 0.918 |
| Age (years) | 54.17±8.67 | 53.47±7.73 | 0.362 | 0.719 |
| Duration of diabetes (years) | 9.94±5.10 | N/A | N/A | N/A |
| BCVA-OD | 0.49±0.19 | 1.18±0.16 | −16.461 | <0.001 |
| BCVA-OS | 0.52±0.14 | 1.13±0.18 | −15.876 | <0.001 |
| HbA1c (%) | 7.47±1.26 | 5.59±0.39 | 8.442 | <0.001 |
| Fasting blood glucose (mmol/L) | 8.23±2.30 | 5.96±0.48 | 5.758 | <0.001 |
Notes: Chi-squared test for sex (n). Independent samples t-test for the other normally distributed continuous data (means ±SD). *P<0.05 indicated significant differences.
Abbreviations: DR, diabetic retinopathy; HC, healthy control; N/A, not applicable; BCVA, best corrected visual acuity; OD, oculus dexter; OS, oculus sinister; Hb, glycosylated hemoglobin.